Ion Cotarla
Impact in
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 10%
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 6
-
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Ramona Dumitrescu (1 shared paper)Brian Seal (3 shared papers)Alyssa Klein (1 shared paper)Apar Kishor Ganti (1 shared paper)Engels Chou (1 shared paper)Priscilla A. Furth (3 shared papers)Shuxun Ren (2 shared papers)Baljit Singh (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Chemotherapy and Pharmacology (2 papers)Future Oncology (1 paper)JAMA Oncology (1 paper)The Oncologist (1 paper)
- Partner nations
- United StatesJapanAustria
In The Last Decade
Ion Cotarla
18 papers receiving 1.1k citations
Ion Cotarla's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 447
- Cancer Research 145
- Pulmonary and Respiratory Medicine 266
- Geriatrics and Gerontology 16
- Molecular Biology 337
Countries citing papers authored by Ion Cotarla
This map shows the geographic impact of Ion Cotarla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ion Cotarla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ion Cotarla more than expected).
Fields of papers citing papers by Ion Cotarla
This network shows the impact of papers produced by Ion Cotarla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ion Cotarla. The network helps show where Ion Cotarla may publish in the future.
Co-authors
The 25 scholars most cited alongside Ion Cotarla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US Hit paper breakdown → | 2021 | 432 |
| 2 | 2005 | 365 | |
| 3 | 2003 | 121 | |
| 4 | 2012 | 68 | |
| 5 | 2012 | 61 | |
| 6 | 2002 | 27 | |
| 7 | 2009 | 17 | |
| 8 | 2008 | 15 | |
| 9 | 2012 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2007 | 9 | |
| 12 | Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment | 2022 | 8 |
| 13 | 2023 | 6 | |
| 14 | 2010 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2022 | 0 |
About Ion Cotarla
Ion Cotarla is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Cancer Research, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Economic and Financial Impacts of Cancer (2 papers), Estrogen and related hormone effects (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Oncology (447 citations), Cancer Research (145 citations), Pulmonary and Respiratory Medicine (266 citations), Geriatrics and Gerontology (16 citations) and Molecular Biology (337 citations). Ion Cotarla has collaborated with scholars based in United States, Japan and Austria. Frequent co-authors include Ramona Dumitrescu, Brian Seal, Alyssa Klein, Apar Kishor Ganti, Engels Chou, Priscilla A. Furth, Shuxun Ren, Baljit Singh, Ying Zhang and Edmund A. Gehan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Future Oncology, JAMA Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.